968 results on '"Sakamaki H"'
Search Results
2. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia
3. Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy
4. Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT
5. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT
6. Risk factors and organ involvement of chronic GVHD in Japan
7. Tobacco smoking is associated with infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
8. Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
9. Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation
10. Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation
11. Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
12. Salvage allogeneic hematopoietic SCT for primary graft failure in children
13. The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis
14. New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function
15. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry
16. The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT
17. Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR
18. Second allogeneic hematopoietic SCT for relapsed ALL in children
19. Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation
20. Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan
21. Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant
22. Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis
23. Secondary solid tumors after allogeneic hematopoietic SCT in Japan
24. Clinical impact of pre-transplant diastolic function on outcome after allogeneic hematopoietic SCT
25. Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution
26. Air-leak syndrome following allo-SCT in adult patients: report from the Kanto Study Group for Cell Therapy in Japan
27. A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor
28. Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia
29. A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT
30. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation
31. THE ANALYSIS OF HEMATOGONES (HGS) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT): PH-P386
32. Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT
33. Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
34. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT
35. Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey
36. P22.06 A Large Solitary Fibrous Tumor of the Pleura Causing Paraneoplastic Hypoglycemia
37. Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia
38. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease
39. Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years
40. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome
41. Recovery of Vα24+ NKT cells after hematopoietic stem cell transplantation
42. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan
43. Allogeneic myeloablative transplantation for patients aged 50 years and over
44. Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate
45. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation
46. Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT
47. Clinical features and treatment of hematopoietic stem cell transplantation-associated gastric antral vascular ectasia
48. Visceral varicella zoster virus infection after allogeneic stem cell transplantation
49. Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
50. Clinical outcomes of allogeneic haematopoietic stem cell transplantation with intravenous busulfan-based reducedintensity conditioning for acute myeloid leukaemia: a nationwide retrospective study from the adult AML working group of JSHCT: O380
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.